77 related articles for article (PubMed ID: 1798710)
1. [PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements].
Kertscher HP; Ostermann G; Findeisen M; Limmer S; Gawrisch K
Pharmazie; 1991 Aug; 46(8):575-9. PubMed ID: 1798710
[TBL] [Abstract][Full Text] [Related]
2. [PAF-antagonists with phospholipid structure. 2. Phospholipids with heteroarene head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationships].
Kertscher HP; Ostermann G
Pharmazie; 1991 Oct; 46(10):708-11. PubMed ID: 1803385
[TBL] [Abstract][Full Text] [Related]
3. [PAF-antagonists with a phospholipid structure. 5. Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variations of the phosphorus-nitrogen distance;synthesis, characterization and structure activity relationship].
Kertscher HP; Schwabe W; Grupe R
Pharmazie; 1993 Jan; 48(1):23-6. PubMed ID: 8460172
[TBL] [Abstract][Full Text] [Related]
4. [PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Schmidt B; Ostermann G
Pharmazie; 1992 Mar; 47(3):172-4. PubMed ID: 1615020
[TBL] [Abstract][Full Text] [Related]
5. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Ostermann G
Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226
[TBL] [Abstract][Full Text] [Related]
6. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
Favre E; Heymans F; Redeuilh C; Batt JP; Massicot F; Blavet N; Braquet P; Godfroid JJ
J Lipid Mediat; 1992 Feb; 5(1):23-40. PubMed ID: 1449553
[TBL] [Abstract][Full Text] [Related]
8. [PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship].
Kertscher HP
Pharmazie; 1997 Sep; 52(9):672-5. PubMed ID: 9411454
[TBL] [Abstract][Full Text] [Related]
9. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator.
Hofmann B; Ostermann G; Hoffmann A; Klöcking HP; Kertscher HP
Biomed Biochim Acta; 1988; 47(10-11):S157-60. PubMed ID: 3248103
[TBL] [Abstract][Full Text] [Related]
10. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. II. Relationships between chemical structure and inhibition of PAF-induced human platelet activation.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1991; 3(2):225-37. PubMed ID: 1797154
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor.
Sugiura T; Tokumura A; Gregory L; Nouchi T; Weintraub ST; Hanahan DJ
Arch Biochem Biophys; 1994 Jun; 311(2):358-68. PubMed ID: 8203898
[TBL] [Abstract][Full Text] [Related]
12. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
Takatani M; Maezaki N; Imura Y; Terashita Z; Nishikawa K; Tsushima S
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():943-6. PubMed ID: 1825438
[No Abstract] [Full Text] [Related]
13. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
15. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
Hofmann B; Ostermann G; Kertscher HP; Till U
Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200
[TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
[TBL] [Abstract][Full Text] [Related]
17. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
Issekutz AC; Szpejda M
Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
[TBL] [Abstract][Full Text] [Related]
18. Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat.
Hofmann B; Meisgeier U; Kertscher P; Ostermann G
Biomed Biochim Acta; 1988; 47(10-11):S161-4. PubMed ID: 3150268
[TBL] [Abstract][Full Text] [Related]
19. Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
Trova MP; Wissner A; Carroll ML; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Kohler CA
J Med Chem; 1993 Mar; 36(5):580-90. PubMed ID: 8496938
[TBL] [Abstract][Full Text] [Related]
20. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
